Woodline Partners’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Sell |
1,001,360
-1,484,218
| -60% | -$5.4M | 0.02% | 618 |
|
|
2025
Q1 | $4.77M | Buy |
+2,485,578
| New | +$4.77M | 0.03% | 521 |
|
|
2022
Q1 | – | Sell |
-2,231,966
| Closed | -$5.04M | – | 715 |
|
|
2021
Q4 | $5.04M | Sell |
2,231,966
-91,551
| -4% | -$207K | 0.07% | 279 |
|
|
2021
Q3 | $6.69M | Buy |
2,323,517
+2,199,743
| +1,777% | +$6.34M | 0.11% | 215 |
|
|
2021
Q2 | $469K | Buy |
+123,774
| New | +$469K | 0.01% | 476 |
|
|
2021
Q1 | – | Sell |
-2,382,522
| Closed | -$6.67M | – | 428 |
|
|
2020
Q4 | $6.67M | Sell |
2,382,522
-3,076,414
| -56% | -$8.61M | 0.18% | 141 |
|
|
2020
Q3 | $13.7M | Buy |
5,458,936
+4,814,707
| +747% | +$12.1M | 0.45% | 65 |
|
|
2020
Q2 | $8.75M | Buy |
644,229
+17,519
| +3% | +$238K | 0.35% | 80 |
|
|
2020
Q1 | $4.75M | Sell |
626,710
-646,077
| -51% | -$4.9M | 0.34% | 88 |
|
|
2019
Q4 | $8.04M | Buy |
+1,272,787
| New | +$8.04M | 0.33% | 76 |
|